Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase 2 9Phase 3 7Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 1Melanoma 1

Interventions

Blood Specimen Collection 11Radiosurgery 7Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Sentinel Lymph Node Biopsy 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4Surgical Procedures, Operative 3Nivolumab 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2X-Rays 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Interleukin-2 2In Situ Hybridization, Fluorescence 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Melanoma × Introns × Clear all
NCT01460875 2018-11-02

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
34 enrolled 12 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡